Please login to the form below

Not currently logged in
Email:
Password:

oral myeloma therapy

This page shows the latest oral myeloma therapy news and features for those working in and with pharma, biotech and healthcare.

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Takeda can't sway NICE on oral myeloma therapy Ninlaro. Drug not recommended for NHS use in England and Wales. ... NICE has stuck to its decision not to recommend Takeda's multiple myeloma therapy Ninlaro for routine use in the NHS in England and Wales

Latest news

  • Novel therapies for blood cancers showcased at ASH Novel therapies for blood cancers showcased at ASH

    Meanwhile, CAR-T therapy has also been shown for the first time at this year's ASH to have a therapeutic benefit in multiple myeloma. ... cancer. There was also encouraging new data for Takeda's multiple myeloma therapy Ninlaro (ixazomib; MLN9708), which

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics